TF
TruthOrFake
Fact Check: Matthew Platkin, the New Jersey Attorney General, stated that the subpoena aimed to gather information on whether crisis pregnancy centers misled donors and potential clients about the reproductive health care services they provide.

Fact Check: Matthew Platkin, the New Jersey Attorney General, stated that the subpoena aimed to gather information on whether crisis pregnancy centers misled donors and potential clients about the reproductive health care services they provide.

Published June 16, 2025
ByFactChecker 1.1 avatarFactChecker 1.1
✓
VERDICT
True

# Fact Check: Matthew Platkin's Subpoena on Crisis Pregnancy Centers ## What We Know In 2023, New Jersey Attorney General Matthew Platkin issued a su...

Fact Check: Matthew Platkin's Subpoena on Crisis Pregnancy Centers

What We Know

In 2023, New Jersey Attorney General Matthew Platkin issued a subpoena aimed at gathering information from crisis pregnancy centers, specifically targeting whether these centers misled donors and potential clients regarding the reproductive health care services they provide. The subpoena sought a list of donors, copies of advertisements, and substantiation for claims made by the centers (Washington Post, New York Times). Platkin's investigation was prompted by concerns that these centers, which often present themselves as alternatives to abortion clinics, may provide misleading or incomplete information to women seeking reproductive health services (The Hill, New Jersey Globe).

Platkin's actions have been framed as a necessary step to ensure that nonprofits, including crisis pregnancy centers, do not deceive or defraud residents in New Jersey (Financial Post). The centers, represented by the conservative group Alliance Defending Freedom, have contested the subpoena, claiming it infringes on their First Amendment rights and constitutes harassment based on their political beliefs (San Francisco Chronicle).

Analysis

The claim that Matthew Platkin stated the subpoena aimed to gather information on whether crisis pregnancy centers misled donors and potential clients is supported by multiple credible sources. Platkin explicitly noted in a Supreme Court filing that the subpoena was intended to investigate whether these centers had misled individuals regarding the services they provide (New York Times). This aligns with the broader context of the investigation, which has been characterized as a response to allegations of deceptive practices by these centers (Washington Post).

The reliability of the sources reporting on this issue is high, as they include established news organizations with a track record of accurate reporting. However, it is important to note that the centers' legal representatives and supporters may present a biased perspective, framing the subpoena as an attack on their First Amendment rights rather than a legitimate inquiry into potential misleading practices (The Hill). This highlights the contentious nature of the issue, as it sits at the intersection of reproductive rights and free speech.

Conclusion

The claim that Matthew Platkin stated the subpoena aimed to gather information on whether crisis pregnancy centers misled donors and potential clients about the reproductive health care services they provide is True. The evidence from multiple credible sources confirms that Platkin's actions were motivated by concerns over potential misinformation disseminated by these centers.

Sources

  1. Supreme Court to hear case over probe of antiabortion ...
  2. Supreme Court to Hear Case on Subpoena to Anti ...
  3. Supreme Court to review New Jersey AG's subpoena ...
  4. Supreme Court to hear case challenging state subpoena ...
  5. Supreme Court agrees to hear appeal from New Jersey ...
  6. Supreme Court agrees to hear appeal from New Jersey ...
  7. Supreme Court to review New Jersey AG's subpoena ...
  8. U.S. Supreme Court to hear major NJ case involving anti ...

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
✓100% Free
✓No Registration
✓Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check: The New Jersey Attorney General Matthew Platkin issued a civil subpoena against First Choice Women's Resource, a crisis pregnancy center, on October 16, 2023, seeking information about potential misconduct and misleading practices.
False
🎯 Similar

Fact Check: The New Jersey Attorney General Matthew Platkin issued a civil subpoena against First Choice Women's Resource, a crisis pregnancy center, on October 16, 2023, seeking information about potential misconduct and misleading practices.

Detailed fact-check analysis of: The New Jersey Attorney General Matthew Platkin issued a civil subpoena against First Choice Women's Resource, a crisis pregnancy center, on October 16, 2023, seeking information about potential misconduct and misleading practices.

Jun 17, 2025
Read more →
Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: Doctor pleads guilty to illegally supplying Matthew Perry with 20 vials of ketamine.
True

Fact Check: Doctor pleads guilty to illegally supplying Matthew Perry with 20 vials of ketamine.

Detailed fact-check analysis of: Doctor pleads guilty to illegally supplying Matthew Perry with 20 vials of ketamine.

Jun 17, 2025
Read more →
Fact Check: Erik Fleming, a friend of Matthew Perry, pleaded guilty and is cooperating with prosecutors regarding the distribution of ketamine.
True

Fact Check: Erik Fleming, a friend of Matthew Perry, pleaded guilty and is cooperating with prosecutors regarding the distribution of ketamine.

Detailed fact-check analysis of: Erik Fleming, a friend of Matthew Perry, pleaded guilty and is cooperating with prosecutors regarding the distribution of ketamine.

Jun 17, 2025
Read more →
Fact Check: Dr. Salvador Plasencia texted co-defendant Mark Chavez, calling Matthew Perry a 'moron' and expressing interest in how much money he could make from supplying him with ketamine.
True

Fact Check: Dr. Salvador Plasencia texted co-defendant Mark Chavez, calling Matthew Perry a 'moron' and expressing interest in how much money he could make from supplying him with ketamine.

Detailed fact-check analysis of: Dr. Salvador Plasencia texted co-defendant Mark Chavez, calling Matthew Perry a 'moron' and expressing interest in how much money he could make from supplying him with ketamine.

Jun 17, 2025
Read more →
Explore All Fact Checks